MYGN
MYRIAD GENETICS INC
MYRIAD GENETICS INC (MYGN) has 18 SEC Form 4 filings (18 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jun 12, 2026.
- Industry:Medical - Diagnostics & Research
- CEO:Samraat S Raha
- Employees:2,700
- HQ:Salt Lake City, UT, US
- IPO:1995-10-06
Insider Buying
$28K
reported purchases (SEC code P)
Insider Selling
$67K
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$514.7M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Kumar RashmiFirst filing | Director | Sale | 15,000 | $67K | Jun 9 | SEC ↗ |
| Director | Purchase | 7,500 | $28K | May 14 | SEC ↗ |
Related companies
MYRIAD GENETICS INC is in the Healthcare sector.